Cargando…
Thiopurine dose intensity and treatment outcome in childhood lymphoblastic leukaemia: the influence of thiopurine methyltransferase pharmacogenetics
The impact of thiopurine methyltransferase (TPMT) genotype on thiopurine dose intensity, myelosuppression and treatment outcome was investigated in the United Kingdom childhood acute lymphoblastic leukaemia (ALL) trial ALL97. TPMT heterozygotes had significantly more frequent cytopenias and therefor...
Autores principales: | Lennard, Lynne, Cartwright, Cher S., Wade, Rachel, Vora, Ajay |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4737107/ https://www.ncbi.nlm.nih.gov/pubmed/25441457 http://dx.doi.org/10.1111/bjh.13240 |
Ejemplares similares
-
Thiopurine methyltransferase and treatment outcome in the UK acute lymphoblastic leukaemia trial ALL2003
por: Lennard, Lynne, et al.
Publicado: (2015) -
Pharmacogenetics of thiopurine therapy: from thiopurine S-methyltransferase to S-adenosylmethionine
por: Mlinarič-Raščan, Irena, et al.
Publicado: (2009) -
Meta-analysis of randomized trials comparing thiopurines in childhood acute lymphoblastic leukaemia
por: Escherich, Gabriele M, et al.
Publicado: (2011) -
Pharmacogenetics of thiopurines
por: Franca, Raffaella, et al.
Publicado: (2019) -
Pharmacogenetic studies of thiopurine methyltransferase genotype‐phenotype concordance and effect of methotrexate on thiopurine metabolism
por: Zimdahl Kahlin, Anna, et al.
Publicado: (2020)